Retina On Line


New publications & announcements about retina & posterior segment


Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials.

Dugel PU, Hillenkamp J, Sivaprasad S, Vögeler J, Mousseau MC, Wenzel A, Margaron P, Hashmonay R, Massin P.

Clin Ophthalmol. 2016 Jun 14;10:1103-10. doi: 10.2147/OPTH.S100764. eCollection 2016.

PMID: 27366049

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab.

Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS.

Clin Ophthalmol. 2016 Jun 8;10:1053-7. doi: 10.2147/OPTH.S109894. eCollection 2016.

PMID: 27354759

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement.

Hirakata T, Fujinami K, Watanabe K, Sasaki M, Noda T, Akiyama K.

Clin Ophthalmol. 2016 May 26;10:969-77. doi: 10.2147/OPTH.S101596. eCollection 2016.

PMID: 27307700


Intravitreal aflibercept for myopic choroidal neovascularization.

Pece A, Milani P.

Graefes Arch Clin Exp Ophthalmol. 2016 Jun 11. [Epub ahead of print]

PMID: 27286893

Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.

Massamba N, Dirani A, Butel N, Fardeau C, Bodaghi B, Ingram A, Lehoang P.

Graefes Arch Clin Exp Ophthalmol. 2016 Jul 11. [Epub ahead of print]

PMID: 27397583

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials.

Oellers P, Grewal DS, Fekrat S.

Clin Ophthalmol. 2016 Mar 8;10:411-8. doi: 10.2147/OPTH.S98853. eCollection 2016. Review.

PMID: 27022238

Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid.

Jaffe GJ, Kaiser PK, Thompson D, Gibson A, Saroj N, Vitti R, Berliner AJ, Heier JS.

Ophthalmology. 2016 Jun 28. pii: S0161-6420(16)30320-7. doi: 10.1016/j.ophtha.2016.05.016. [Epub ahead of print]

PMID: 27369111

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW; Diabetic Retinopathy Clinical Research Network.

Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27.